Tudor Investment Corp’s AVANIR PHARMACEUTICALS, INC CL A AVNR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-22,895
Closed -$388K 1786
2014
Q4
$388K Sell
22,895
-104,575
-82% -$1.47M 0.01% 890
2014
Q3
$1.52M Buy
+127,470
New +$870K 0.05% 173
2013
Q4
Sell
-42,100
Closed -$178K 1445
2013
Q3
$178K Buy
+42,100
New +$199K 0.01% 748

Tudor Investment Corp's AVNR Position: Q1 2015 in Review

Tudor Investment Corp sold out of AVANIR PHARMACEUTICALS, INC CL A (AVNR) in Q1 2015, closing a stake of 22,895 shares — an estimated $388K sold.

Tudor Investment Corp first reported a position in AVNR in Q3 2013 and held it in 3 quarters. The position peaked at $1.52M in Q3 2014. 0 funds tracked by Wall St. Rank hold AVNR as of Q1 2015.

  • Tudor Investment Corp reported no remaining AVANIR PHARMACEUTICALS, INC CL A position as of Q1 2015 after selling out during the quarter.
  • Tudor Investment Corp sold 22,895 AVANIR PHARMACEUTICALS, INC CL A shares in Q1 2015, an estimated $388K.
  • Tudor Investment Corp first reported a position in AVANIR PHARMACEUTICALS, INC CL A in Q3 2013 and held it in 3 quarters.
  • Tudor Investment Corp's AVANIR PHARMACEUTICALS, INC CL A position peaked at $1.52M in Q3 2014.
  • 0 funds tracked by Wall St. Rank held AVANIR PHARMACEUTICALS, INC CL A as of Q1 2015.

Based on Tudor Investment Corp's 13F filing for Q1 2015, filed 15 May 2015.